Back to Search
JEFFREY SCHRIBER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1851369821IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25423(AZ)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF TORONTO, FACULTY OF MEDICINE
Class of 1986
Research & Publications (14)
Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates.
PMID 18342788·Biol Blood Marrow Transplant·2008
8-other
Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor.
PMID 18084336·Bone Marrow Transplant·2008
5-case
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma.
PMID 17448919·Biol Blood Marrow Transplant·2007
3-trial
Multiple myeloma. Clinical practice guidelines in oncology.
PMID 17335683·J Natl Compr Canc Netw·2007
6-review
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
PMID 16737937·Biol Blood Marrow Transplant·2006
8-other
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
PMID 16275593·Biol Blood Marrow Transplant·2005
3-trial
Successful allogeneic bone marrow transplantation in a patient with active Coccidioidomycosis.
PMID 15778732·Bone Marrow Transplant·2005
5-case
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
PMID 15143076·J Clin Oncol·2004
8-other
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
PMID 15064696·Bone Marrow Transplant·2004
3-trial
Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim.
PMID 12479593·Drugs·2002
6-review
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
PMID 11781646·Bone Marrow Transplant·2001
3-trial
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
PMID 11401310·Br J Cancer·2001
3-trial
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
PMID 11319593·Bone Marrow Transplant·2001
4-observational
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
PMID 10905773·Biol Blood Marrow Transplant·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10460 N 92ND ST STE 200
SCOTTSDALE, AZ 85258 - Phone
- (480) 323-1573
Quick Facts
- NPI
- 1851369821
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 14
Are you this provider?
Claim Your Profile